Characteristics | Control group (n = 108) | Intervention group (n = 105) | P value |
---|---|---|---|
Sex | |||
Male | 54 (50,0%) | 51 (48,6%) | 0,835 |
Female | 54 (50,0%) | 54 (51,4%) | |
Age (in years) | 63,2 ± 14,5 | 59,4 ± 14,5 | 0,059 |
Causes for intubation | |||
Acute respiratory failure secondary to pulmonary event | 23 (21,3%) | 29 (27,6%) | 0,610 |
Acute respiratory failure secondary to cardiovascular event | 51 (47,2%) | 43 (40,9%) | |
Acute respiratory failure secondary to neuromuscular event | 6 (5,6%) | 8 (7,6%) | |
Acute respiratory failure secondary to foreing body aspiration | 1 (0,9%) | 0 (-) | |
Other cause | 27 (25,0%) | 25 (23,8%) | |
Intubation process | |||
Elective | 23 (21,3%) | 27 (25,7%) | 0,678 |
Urgent | 78 (72,2%) | 70 (66,7%) | |
Emergency | 7 (6,5%) | 8 (7,6%) | |
Previous antibiotic use | |||
Yes | 21 (19,4%) | 26 (24,8%) | 0,349 |
No | 87 (80,6%) | 79 (75,2%) | |
APACHE II | 22,2 ± 7,7 | 21,9 ± 7,5 | 0,767 |
Admission diagnosis | |||
Pulmonary disease | 8 (18,6%) | 5 (15,2%) | 0,586 |
Cardiovascular disease | 25 (58,1%) | 23 (69,7%) | |
Endocrine disease | 2 (4,6%) | 2 (6,1%) | |
Cerebrovascular disease | 0 (-) | 1 (3,0%) | |
Kidney disease | 4 (9,3%) | 1 (3,0%) | |
Digestive disease | 2 (4,6%) | 1 (3,0%) | |
Other | 2 (4,6%) | 0 (-) | |
Comorbidities | |||
Pulmonary disease | 25 (23,2%) | 22 (21,0%) | 0,699 |
Cardiovascular disease | 92 (85,2%) | 83 (79,1%) | 0,242 |
Endocrine disease | 66 (61,1%) | 54 (51,4%) | 0,154 |
Cerebrovascular disease | 9 (8,3%) | 11 (10,5%) | 0,592 |
Kidney disease | 22 (20,4%) | 27 (25,7%) | 0,354 |
Digestive disease | 13 (12,0%) | 17 (16,2%) | 0,384 |
Hematologic disease | 5 (4,6%) | 4 (3,8%) | 0,766 |